EDSA Edesa Biotech Inc
Price (delayed)
$1.9473
Market cap
$6.75M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.93
Enterprise value
$5.74M
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases with clear unmet medical needs. The company's two lead product candidates, EB05
Highlights
EDSA's debt has dropped by 79% year-on-year and by 49% since the previous quarter
Edesa Biotech's EPS has increased by 34% YoY and by 12% from the previous quarter
The quick ratio has shrunk by 78% YoY and by 35% QoQ
The equity has dropped by 72% year-on-year and by 31% since the previous quarter
Key stats
What are the main financial stats of EDSA
Market
Valuations
Earnings
Shares outstanding
3.47M
Market cap
$6.75M
Enterprise value
$5.74M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.19
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$7.01M
Net income
-$6.17M
EBIT
-$6.17M
EBITDA
-$5.98M
Free cash flow
-$4.89M
Per share
Balance sheet
Liquidity
EPS
-$1.93
EPS diluted
-$1.93
Free cash flow per share
-$1.53
Book value per share
$0.61
Revenue per share
$0
TBVPS
$0.54
Total assets
$3.81M
Total liabilities
$1.83M
Debt
$19,867
Equity
$1.98M
Working capital
-$157,205
Debt to equity
0.01
Current ratio
0.91
Quick ratio
0.71
Net debt/EBITDA
0.17
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-105.7%
Return on equity
-164.3%
Return on invested capital
N/A
Return on capital employed
-311.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EDSA stock price
How has the Edesa Biotech stock price performed over time
Intraday
-0.14%
1 week
-2.15%
1 month
3.58%
1 year
-57.11%
YTD
15.91%
QTD
15.91%
Financial performance
How have Edesa Biotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$7.01M
Net income
-$6.17M
Gross margin
N/A
Net margin
N/A
EDSA's net income is up by 26% year-on-year and by 11% since the previous quarter
Edesa Biotech's operating income has increased by 24% YoY and by 16% from the previous quarter
Growth
What is Edesa Biotech's growth rate over time
Valuation
What is Edesa Biotech stock price valuation
P/E
N/A
P/B
3.19
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Edesa Biotech's EPS has increased by 34% YoY and by 12% from the previous quarter
The equity has dropped by 72% year-on-year and by 31% since the previous quarter
EDSA's price to book (P/B) is 28% lower than its 5-year quarterly average of 4.4 and 28% lower than its last 4 quarters average of 4.4
Efficiency
How efficient is Edesa Biotech business performance
The company's return on equity has shrunk by 68% YoY and by 19% QoQ
Edesa Biotech's return on assets has decreased by 28% YoY and by 8% QoQ
Dividends
What is EDSA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EDSA.
Financial health
How did Edesa Biotech financials performed over time
Edesa Biotech's total assets is 108% more than its total liabilities
The quick ratio has shrunk by 78% YoY and by 35% QoQ
EDSA's current ratio has shrunk by 74% YoY and by 29% QoQ
EDSA's debt is 99% smaller than its equity
EDSA's debt has dropped by 79% year-on-year and by 49% since the previous quarter
The equity has dropped by 72% year-on-year and by 31% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.